Mr. Wyden (for himself, Mr. Hatch, Mr. Markey, and Mr. Brown) introduced the following bill; which was read twice and referred to the Committee on Finance
To permanently allow an exclusion under the Supplemental Security Income program and the Medicaid program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Ensuring Access to Clinical Trials Act of 2015. S. 139. 114th
Cong., 1st
sess., Introduced in Senate January 8, 2015. https://www.govinfo.gov/app/details/BILLS-114s139is.
APA
Congress, Senate (2015, January 8). Ensuring Access to Clinical Trials Act of 2015 (S. 139 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-114s139is.
MLA
United States, Congress, Senate. Ensuring Access to Clinical Trials Act of 2015. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-114s139is. 114th Congress, S. 139, Introduced in Senate 8 Jan. 2015.
Bluebook
S.139 - 114th Congress (2015-2016): Ensuring Access to Clinical Trials Act of 2015, S.139, 114th Cong. (2015), https://www.govinfo.gov/app/details/BILLS-114s139is.
